Profil
Carl Walkey is the founder of Ansible Marketing, Inc. (founded in 2014) and Neoleukin Therapeutics, Inc. (founded in 2003).
At Neoleukin Therapeutics, he held the title of Senior Vice President-Corporate Development from 2021 to 2022.
Dr. Walkey earned a doctorate degree from the University of Toronto.
Anciens postes connus de Carl Walkey
Sociétés | Poste | Fin |
---|---|---|
NEUROGENE INC. | Founder | 01/12/2022 |
Ansible Marketing, Inc. | Founder | - |
Formation de Carl Walkey
University of Toronto | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Neoleukin Therapeutics, Inc.
Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
Ansible Marketing, Inc. |